Teladoc Health, Inc.·4

Mar 5, 4:08 PM ET

Trencher Daniel 4

4 · Teladoc Health, Inc. · Filed Mar 5, 2024

Insider Transaction Report

Form 4
Period: 2024-03-01
Trencher Daniel
SVP Corporate Strategy
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-01+3,80320,591 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-0111,16022,322 total
    Common Stock (11,160 underlying)
  • Exercise/Conversion

    Common Stock

    2024-03-01+36420,955 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+72221,677 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+1,17922,856 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+11,16034,016 total
  • Exercise/Conversion

    Common Stock

    2024-03-01+95634,972 total
  • Sale

    Common Stock

    2024-03-04$14.52/sh6,780$98,41828,192 total
  • Award

    Performance Stock Units

    2024-03-01+11,41111,411 total
    Common Stock (11,411 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-013,8037,608 total
    Common Stock (3,803 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-013640 total
    Common Stock (364 underlying)
  • Exercise/Conversion

    Performance Stock Units

    2024-03-017220 total
    Common Stock (722 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-011,1794,717 total
    Common Stock (1,179 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-019560 total
    Common Stock (956 underlying)
Footnotes (12)
  • [F1]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F10]On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F11]On March 3, 2023, the reporting person was granted 33,482 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F12]On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
  • [F2]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  • [F4]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  • [F5]Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  • [F6]The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F7]On March 1, 2024, the reporting person earned 11,411 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  • [F8]On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
  • [F9]On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.

Documents

1 file
  • 4
    wk-form4_1709672868.xmlPrimary

    FORM 4